Market revenue in 2023 | USD 82.3 million |
Market revenue in 2030 | USD 143.6 million |
Growth rate | 8.3% (CAGR from 2023 to 2030) |
Largest segment | Type a |
Fastest growing segment | Type A |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Type A, Type B |
Key market players worldwide | Ipsen SA, Merz Pharma, US WorldMeds, Galderma Group AG Registered Shares, Evolus Inc, Allergan, Metabiologics, Lanzhou Institute Of Biological Products |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to botulinum toxin market will help companies and investors design strategic landscapes.
Type a was the largest segment with a revenue share of 98.66% in 2023. Horizon Databook has segmented the South Africa botulinum toxin market based on type a, type b covering the revenue growth of each sub-segment from 2018 to 2030.
Market growth in South Africa can be attributed to the increasing number of women in the workforce and growing disposable income. Moreover, increasing urbanization is driving the positive trend for beauty and personal care since urban consumers are wealthier.
The country has rich cultural diversity along with high awareness about personal care, which may boost market demand. The demand for facial injectables, such as BoNT, is rapidly increasing in South Africa, which is significantly contributing to the market growth. According to an article by African Daily, the population in South Africa is growing and is expected to double to 2.4 billion in 2050.
According to a factsheet presented by the Department Trade and Industry of Republic of South Africa, rising import demand for esthetic and cosmetic products, increasing demand for organic natural products, access to natural ingredients, and strong R&D capabilities are attracting investments to the country.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa botulinum toxin market , including forecasts for subscribers. This country databook contains high-level insights into South Africa botulinum toxin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account